EZElisa™淀粉样蛋白结合蛋白2（Appbp2）试剂盒-
EZElisa™ Amyloid protein-binding protein 2 (Appbp2) Kit- 询价
- Biogradetech
- 美国
- A-QEK06251-96wells
- 2025年06月28日
企业认证
相关产品推荐更多 >
EZElisa™ RAB37,RAS癌基因家族成员（RAB37）试剂盒-EZElisa™ RAB37, Member RAS Oncogene Family (RAB37) Kit
询价
EZElisa ™ Corticosterone（CORT）ELISA试剂盒（ELISA套件）-EZElisa™ Corticosterone (CORT) ELISA Kit
询价
EZElisa™人细胞周期蛋白依赖性激酶9（CDK9）ELISA试剂盒-EZElisa™ Human Cyclin Dependent Kinase 9 (CDK9) ELISA Kit
询价EZElisa™ 小鼠Interleukin-36 alpha（Il 36 a）ELISA套件-EZElisa™ Mouse Interleukin-36 alpha (Il36a) ELISA Kit
询价EZElisa ™小鼠蛋白DEK（Dek）ELISA试剂盒-EZElisa™ Mouse Protein DEK (Dek) ELISA Kit
询价
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 保存条件：
运输过程中保存：2-8℃
- 保质期：
1年
- 英文名：
EZElisa™ Amyloid protein-binding protein 2 (Appbp2) Kit
- 库存：
100
- 供应商：
艾美捷科技
EZElisa™淀粉样蛋白结合蛋白2（Appbp2）试剂盒，EZElisa™ Amyloid protein-binding protein 2 (Appbp2) Kit，淀粉样蛋白结合蛋白2（Appbp2）试剂盒, Amyloid protein-binding protein 2 (Appbp2) Kit
产品名称：EZElisa™载脂蛋白O（APOO）试剂盒-EZElisa™ Amyloid protein-binding protein 2 (Appbp2) Kit
产品货号：A-QEK06251-96wells
产品规格：96wells
Enzyme Immunoassay for the estimation of EZElisa™ Amyloid protein - binding protein 2 (Appbp2) in serum and plasma, tissue homogenates and other biological fluids.
种属：Human
检测方法：比色法
检测范围：0.313 - 20 ng/ml
该EZElisa™淀粉样蛋白结合蛋白2（Appbp2）试剂盒ELISA的特点包括：即用即用的操作步骤标准化和高重复性批次之间的一致性准确性和精确性经过七个点的验证，符合金环标准质量ELISA的要求，这是Biogradetech质量的基准标志。EZElisa™ ELISA试剂盒用于评估样品中的特定生物标志物，样品可以是血清
运输过程中保存：2-8℃
点击：EZElisa™载脂蛋白O（APOO）试剂盒-EZElisa™ Amyloid protein-binding protein 2 (Appbp2) Kit更多Biogradetech产品信息价格，货期，产品说明，百度搜“艾美捷科技”进入官网网站，查看具体产品且快速下单。
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Prion Protein as Copper-Binding Protein at the Synapse
(1 ). The glial fibrillary acidic protein was one of the first possible binding partners to be described (2 ) followed by Bcl-2 (3 ,4 ), molecular chaperones (5) , amyloid precursor-like protein 1 (6 ), the 37-kDa laminin receptor (7 ) and a 66-kDa membrane
Methods for Studying Prion Protein Amyloid
Prion encephalopathies are neurodegenerative diseases characterized by the accumulation of abnormal isoforms of the prion protein (PrP) and the deposition of PrP amyloid in the central nervous systein (CNS) (1 , 2 ) The diseasespecific PrP
Interaction of the Presenilins with the Amyloid Precursor Protein (APP)
the deposition of amyloid Aβ peptide. The latter is released from its cognate amyloid precursor protein (APP) by a two-step proteolytic conversion: first, proteolysis of APP by β-secretase, which releases the N-terminus of Aβ, and second, conversion
技术资料暂无技术资料 索取技术资料
